Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

B of A Securities Downgrades Singular Genomics Sys to Underperform, Announces $3 Price Target

B of A Securities analyst Michael Ryskin downgrades Singular Genomics Sys (NASDAQ:OMIC) from Buy to Underperform and announces $3 price target.
byBenzinga Newsdesk
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

B of A Securities analyst Michael Ryskin downgrades Singular Genomics Sys (NASDAQ:OMIC) from Buy to Underperform and announces $3 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts